Cancer Care Associates-Norman
Norman, Oklahoma, United States
Doctor in Norman, Oklahoma
701 E Robinson St #100, Norman, OK 73071
About Cancer Care Associates-Norman
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
14
Alliance for Clinical Trials in Oncology
4
Celgene
3
SWOG Cancer Research Network
3
ECOG-ACRIN Cancer Research Group
2
NSABP Foundation Inc
2
University of South Florida
1
Clinical Trials at Cancer Care Associates-Norman
During the past decade, Cancer Care Associates-Norman conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 20 clinical trials were completed, i.e. on
average, 666.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
2008-10-13
2017-06-15
Completed
799
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
2009-10-01
2019-07-01
Completed
144
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Care Associates-Norman" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials
sponsored, "Celgene" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 3 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care Associates-Norman"
#1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Aptuit" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Cancer Care Associates-Norman
According to Clinical.Site data, the most researched conditions in "Cancer Care Associates-Norman" are
"Breast Cancer" (5 trials), "Crohn Disease" (3 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Cancer Care Associates-Norman" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Care Associates-Norman
Most popular intervention types in "Cancer Care Associates-Norman" are "Drug" (26 trials), "Other" (22 trials), "Biological" (12 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Bevacizumab" (6 trials), "Quality-of-Life Assessment" (6 trials), "placebo" (5 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Care Associates-Norman
The vast majority of trials in "Cancer Care Associates-Norman" are
26 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Cancer Care Associates-Norman
Currently, there are NaN active trials in "Cancer Care Associates-Norman".
undefined are not yet recruiting,
3 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Cancer Care Associates-Norman,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Care Associates-Norman, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".